Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CERULOPLASMIN - ANVISA Registration 10287410094

Access comprehensive regulatory information for CERULOPLASMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287410094 and manufactured by DAKO DENMARK A/S - DINAMARCA PARA ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNร“STICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SENTINEL CH. SPA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10287410094
Registration Details
ANVISA Registration Number: 10287410094
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

TINA QUANT (a) CERULOPLASMINA
Risk Class II

Registration Details

10287410094

25351027181200313

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Aug 08, 2003

VIGENTE

09/18/2025 19:00:01